DS

Drishti Sharma

Active Director Director DIN 09305297
DIN 09305297 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Drishti Sharma

Data last updated:

Drishti Sharma is a Director at Goodhums Lifesciences Private Limited (since 2021). The company operates in Pharma. Goodhums Lifesciences Private Limited reported revenue of ₹53.3 Lakh (FY 2025).

DIN 09305297
Primary Designation Director
Industry Pharma
First Appointment 06 Sep 2021
Oldest Company Age 8 yrs
Largest company Goodhums Lifesciences Private Limited · ₹53.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Sep 20212018₹53.3 Lakh (FY 2025)Active

Board colleagues of Drishti Sharma

Directorship timeline

Open interactive timeline →
Goodhums Lifesciences Private Limited
Premium access

Shareholding and investment profile for Drishti Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Drishti Sharma

Drishti Sharma currently holds 1 directorship: Goodhums Lifesciences Private Limited (Director, since 06 Sep 2021, revenue ₹53.3 Lakh (FY 2025)).

Drishti Sharma was first appointed on 06 Sep 2021 as Director at Goodhums Lifesciences Private Limited.

The current boards of Drishti Sharma's companies include Ranjeet Mishra (Goodhums Lifesciences Private Limited), Virender Kumar Suri (Goodhums Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available